A prospective analysis of patients with heart failure and reduced ejection fraction in Japan found that the proportion receiving angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists decreased as physical frailty increased.
20 Jun 2023
The President-elect of the American Medical Women's Association discusses mentorship, advocacy, and more.
1 Sep 2023
Positive airway pressure-adherent patients with heart failure with preserved ejection fraction and obstructive sleep apnea had fewer health care visits, including ED and hospital visits, than nonadherent patients, according to a new industry-funded study.
18 Jul 2023
Adding a sodium-glucose cotransporter-2 inhibitor to standard care had intermediate cost-effectiveness, but replacing an angiotensin-converting enzyme inhibitor with an angiotensin receptor-neprilysin inhibitor was only borderline cost-effective, a modeling study found.
13 Jun 2023
An expert discusses causes and effects of health disparities as well as ways to incorporate health equity into the practice of medicine.
1 Jul 2023
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
14 Dec 2021
This month's expert discusses measuring vital signs, orthostatic hypotension, and the cardiac exam in the context of inpatient care.
1 Jul 2023
A cohort study that analyzed encounters in one health system for worsening heart failure found that ED and observation stays and outpatient visits account for approximately half of the visits, with hospitalizations comprising the other half.
5 Jul 2022
Comanaging cardiology patients after heart failure requires small adjustments, following recent guidelines, and patient involvement in decisions.
1 Jul 2021
The updated guideline recommends sodium-glucose cotransporter-2 inhibitors for many heart failure patients, regardless of their diabetes status, among other changes.
5 Apr 2022